ライフサイエンスコーパス: medical technology

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 dies that report information on usage of new medical technology.

2 gnostic technologies differ from therapeutic medical technologies.

3 ares favorably with other currently accepted medical technologies.

4 useful questions about the acceptance of new medical technologies.

5 ny applications ranging from data storage to medical technologies.

6 ull atropine dose from the Atropen (Meridian Medical Technologies) (0.5 mg) or Mark 1 kits (2 mg), wh

7 The use and misuse of medical technology also pose risks, such as drug-resista

8 prostate cancer is attributed to changes in medical technology and screening practices.

9 effectiveness, best practices, diffusion of medical technologies, and quality of care.

10 childhood conditions, advances in home-based medical technology, and changes in attitudes about pedia

11 technology, semiconductor-based technology, medical technology, anticorrosion and lubricant technolo

12 risks typically associated with translating medical technologies as they move toward prototypes, pre

13 , we could become global leaders not only in medical technology, as we currently are, but also in hea

14 calculated by using Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psy

15 nclude with a consideration of the limits of medical technology assessment.

16 e use of a Nomag IC 1.5 incubator by Lammers Medical Technology Co., equipped with three coils: an ei

17 data, the Mark 1 autoinjector kit (Meridian Medical Technologies, Columbia, Maryland, USA) appears t

18 Physics-based medical technology developed rapidly during the 19th cen

19 Emerging medical technologies for effective and lasting repair of

20 (FDG) is a relatively recent addition to the medical technology for imaging of cancer, and FDG PET co

21 These and other advances in medical technology have changed the standard of care for

22 As with many applications of domiciliary medical technology, home ventilatory support has either

23 ds that consider the resources consumed by a medical technology in decisions about how best to use th

24 Initial clinical studies of new medical technologies involve a complex balance of resear

25 Medical technology is a two-edged sword, capable of savi

26 Medical technology is increasingly costly in most fields

27 health care system with selective access to medical technology is unknown.

28 The Center for Medical Technology Policy and the Molecular Evidence Dev

29 A meeting was hosted by the Center for Medical Technology Policy in Baltimore, MD, on November

30 In this era of advanced medical technology, recurrent ovarian cancer continues t

31 However, the origins of such breakthrough medical technologies remain poorly understood.

32 health services researchers, specialists in medical technologies, representatives of the imaging ind

33 atment (photosensitizer and light) (Miravant Medical Technologies, Santa Barbara, California), photos

34 ted circuitry, optical computing, solar, and medical technologies, setting high expectations for many

35 ogical and Physical Medicine Devices reviews medical technologies that interface with the nervous sys

36 pt of brain death coincided with advances in medical technology that facilitated artificial ventilati

37 Like many medical technologies, the bispectral index (BIS) monitor

38 h and the advancement of adaptive, practical medical technologies to support and sustain military hea

39 t reviews methods for economic evaluation of medical technologies, with a particular focus on cost-ef

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。